Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

From genetic causality to druggable targets: A multiomics framework identifies ZSCAN16 in gout pathogenesis

Submitted by Anna Hakala on Mon, 12/15/2025 - 09:56
  • Read more about From genetic causality to druggable targets: A multiomics framework identifies ZSCAN16 in gout pathogenesis

Exploring the Potential Causal Relationship of Galectin Levels and Gynecologic Cancers: A Two-Sample Mendelian Randomization Study

Submitted by Anna Hakala on Mon, 12/15/2025 - 09:55
  • Read more about Exploring the Potential Causal Relationship of Galectin Levels and Gynecologic Cancers: A Two-Sample Mendelian Randomization Study

Cathepsins effect on diffuse large B cell lymphoma risk: A Mendelian randomization study

Submitted by Anna Hakala on Mon, 12/15/2025 - 09:45
  • Read more about Cathepsins effect on diffuse large B cell lymphoma risk: A Mendelian randomization study

Plasma proteins and osteosarcoma: Mendelian randomization analysis and targeted therapeutic discovery

Submitted by Anna Hakala on Mon, 12/15/2025 - 09:43
  • Read more about Plasma proteins and osteosarcoma: Mendelian randomization analysis and targeted therapeutic discovery

Unraveling the causal landscape of intervertebral disc degeneration: A Mendelian randomization analysis of 108 traits

Submitted by Anna Hakala on Mon, 12/15/2025 - 09:42
  • Read more about Unraveling the causal landscape of intervertebral disc degeneration: A Mendelian randomization analysis of 108 traits

Integrated multi-omics analysis identifies DARS2, MRTO4, and MRPL37 as novel biomarkers and potential therapeutic targets for bladder cancer

Submitted by Anna Hakala on Mon, 12/15/2025 - 09:41
  • Read more about Integrated multi-omics analysis identifies DARS2, MRTO4, and MRPL37 as novel biomarkers and potential therapeutic targets for bladder cancer

Machine learning augmented genome-wide meta-analysis of prescription opioid use in 860,000 individuals

Submitted by Anna Hakala on Thu, 12/11/2025 - 12:29
  • Read more about Machine learning augmented genome-wide meta-analysis of prescription opioid use in 860,000 individuals

Insights into Renal Protein Handling Through GWAS of the Human Urine Proteome

Submitted by Anna Hakala on Thu, 12/11/2025 - 12:27
  • Read more about Insights into Renal Protein Handling Through GWAS of the Human Urine Proteome

Transcriptome-wide association implicates HTRA1-AS1 in age-related macular degeneration risk

Submitted by Anna Hakala on Thu, 12/11/2025 - 12:25
  • Read more about Transcriptome-wide association implicates HTRA1-AS1 in age-related macular degeneration risk

Comprehensive metabolite ratio QTL mapping reveals disease relevant enzyme biology

Submitted by Anna Hakala on Thu, 12/11/2025 - 12:02
  • Read more about Comprehensive metabolite ratio QTL mapping reveals disease relevant enzyme biology

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 53
  • Page 54
  • Page 55
  • Page 56
  • Current page 57
  • Page 58
  • Page 59
  • Page 60
  • Page 61
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement